PRE
Prenetics Global LimitedNASDAQHealthcare$19.68+0.56%ClosedMarket Cap: $276.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.83
P/S
2.95
EV/EBITDA
-6.11
DCF Value
$-1,248.99
FCF Yield
-7.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.0%
Operating Margin
-41.3%
Net Margin
-61.3%
ROE
-36.0%
ROA
-28.7%
ROIC
-22.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $36.6M | 59.5% | $-12.4M | $-28.1M | $-1.75 | — |
| FY 2025 | $92.4M | 53.0% | $-37.4M | $-58.3M | $-4.15 | — |
| Q3 2025 | $23.6M | 59.5% | $-6.2M | $-7.4M | $-0.53 | — |
| Q2 2025 | $17.7M | 41.2% | $-10.1M | $-12.4M | $-0.94 | — |
| Q1 2025 | $17.3M | 42.4% | $-10.6M | $-10.4M | $-0.80 | — |
| Q4 2024 | $10.5M | 37.2% | $-16.6M | $-16.3M | $-1.29 | — |
| FY 2024 | $30.6M | 50.3% | $-48.1M | $-46.3M | $-3.64 | — |
| Q3 2024 | $7.8M | 50.8% | $-11.8M | $-10.7M | $-0.84 | — |
| Q2 2024 | $5.9M | 63.4% | $-10.6M | $-10.7M | $-0.88 | — |
| Q1 2024 | $6.4M | 59.0% | $-9.2M | $-8.6M | $-0.70 | — |
| Q4 2023 | $5.3M | 49.2% | $-11.5M | $-16.9M | $-1.57 | — |
| FY 2023 | $21.7M | 40.6% | $-51.9M | $-62.7M | $-5.58 | — |